Anda di halaman 1dari 47

MCD Immunology

Alexandra Burke-Smith

1. Introduction to Immunology
Professor Charles Bangham (c.bangham@imperial.ac.uk)

1. Explain the importance of immunology for human health.


The immune system
What happens when it goes wrong?
persistent or fatal infections
allergy
autoimmune disease
transplant rejection
What is it for?
To identify and eliminate harmful non-self microorganisms and harmful substances such as toxins, by
distinguishing self from non-self proteins or by identifying danger signals (e.g. from inflammation)
The immune system has to strike a balance between clearing the pathogen and causing accidental damage
to the host (immunopathology).
Basic Principles
The innate immune system works rapidly (within minutes) and has broad specificity
The adaptive immune system takes longer (days) and has exisite specificity
Generation Times and Evolution
Bacteria- minutes
Viruses- hours
Host- years
The pathogen replicates and hence evolves millions of times faster than the host, therefore the host relies
on a flexible and rapid immune response
Out most polymorphic (variable) genes, such as HLA and KIR, are those that control the immune system, and
these have been selected for by infectious diseases

2. Outline the basic principles of immune responses and the timescales in which they occur.
IFN: Interferon (innate immunity)
NK: Natural Killer cells (innate immunity)
CTL: Cytotoxic T lymphocytes (acquired immunity)

MCD Immunology
Innate Immunity
Depends of pre-formed cells and molecules

Fast (starts in mins/hrs)


Limited specifity- pathogen associated, i.e.
recognition of danger signals
Cells involved:
- Neutrophils (PMN)
- Macrophages
- Natural killer (NK) cells

Soluble factors involved


- Acute-phase proteins
- Cytokines
- Complement
Stimulates the acquired immune response

Alexandra Burke-Smith
Acquired immunity
Depends on clonal selection, i.e. growth of T/B
cells, release of antibodies selected for antigen
specifity
Slow (starts in days)
Highly specific to foreign proteins, i.e. antigens
Cells involved :
- T lymphocytes
- B lymphocytes
- Dendritic cells
- Eosinophils
- Basophils/mast cells
Soluble factors involved
- Antibodies

Innate Immunity

Anatomical barriers
Skin as a mechanical barrier- keeps out 95% of household germs while IN TACT
Mucus membrane in respiratory and GI tract traps microbes
Cilial propulsion on epithelia cleans lungs of invading microorganisms

Physiological barriers
Low PH
Secretion of lysozyme, e.g. in tears
Interferons
Antimicrobial peptides
Complement; responsible for lysing microorganisms

Acute-phase inflammatory response


An innate response to tissue damage
Rise in body temperature, i.e. the fever response
This is followed by increased production of a number of proteins (acute-phase proteins), mainly by the liver.
Includes:
- C-reactive protein
- Serum amyloid protein
- Mannan-binding lectin
C-reactive protein and serum amyloid protein bind to molecules found on the cell wall of some bacteria and
fungi- pattern recognition
Mannan-binding lectin binds to mannose sugar molecules which are not often found on mammalian cells
These molecules are non-specific, but direct phagocytes e.g. macrophages to identify and ingest the
infectious agent
Cytokines
Small proteins that carry messages from one cell to another
E.g. to stimulate activation or proliferation of lymphocytes
kick-startacquired immune response
Send messages to other cells, e.g. to kill or secrete
2

MCD Immunology

Alexandra Burke-Smith

Cells of the innate immune system


Granular leukocytes
Natural Killer (NK) cells
- Identify and kill virus-infected and tumour cells
- Complex recognition system- recognise HLA molecule of virus infected cell or tumour, and kill them
Macrophages
- Mononuclear phagocytes
- To main functions:
1. garbage disposal
- 2. Present foreign cells to immune system
Granulocytes
Neutrophils
Poluymorphonuclear
neutrophils (PMN): multilobed nucleus
50-70% of circulating WBC
Phagocytic

Eosinophils
Bi-lobed nucleus

1-3% of circulating WBH

Required for immune


response to parasites,
helminths and allergic
responses

Basophils

<1% of circulating WBC


Not phagocytic- release
granules containing
histamines, serotonin,
prostaglandins
Important in Th2 responseskick starting acquired
immune reponse

3. Define the terms antigen, antibody, B lymphocyte, T lymphocyte, primary and secondary immune
responses, and innate and acquired immunity.
Acquired/Adaptive Immunity
Characteristics
Antigen specific
Can form memory
Requires priming- specific cells help to start the acquired immune response
Cellular Immunity: T and B cells
Humoral immunity: antibodies

Antigens are glycoprotein molecules which react with antibodies or T cells. However not all antigens can induce an
immune response in the host: those that can are termed immunogens
Antibody molecules can be found in the blood stream and the body fluids and bind specifically to particular
molecules termed antigens. They are the acquired component of the humoral immune response.The most basic
antibody molecule is bivalent- with two antigen binding sites.
Immunoglobulins
IgG
- 75% of our serum
- Crosses placenta, therefore important in protecting newborns
- Long serum hal-life
- Part of secondary immune respons
3

MCD Immunology

Alexandra Burke-Smith

Bivalent- two identical antigen binding sites


IgM
10% of total serum Ig
Complex of 5 linked bivalent monomeric antibodies, therefore 10 identical binding sites- multivalent
Star-like shape
Important in primary immune response
Slightly lower affinity to antigens compared to IgG, which is compensated for by number of binding sites

IgA
2 basic monomers; dimer with secretory piece
Found in body secretions, e.g. mucus membranes in GI tract
Contains a secretory component which protects it from digestive enzymes

IgE
Involved in allergic response and the response to helminths
Binds to basophils and mast cells
Triggers release of histamines

IgD
- Complete function not known
A particularly antibody recognizes an antigen because that antibodys binding site it complementary to the
EPIPTOPE (region approx 6 amino acids long) on the antigen. This forms the basis of the specificity of antigen
recognition.
How does an antibody kill a virus?
Four important mechanisms:
1. Binds to the virus and prevents attachment to the cell
2. Opsonisation: virus-antibody complex is recognised and phagocytosed by macrophage
3. Complement- mediated lysis of enveloped viruses: cascade of enzymes in the blood which leads to the
destruction of cell membranes, and the destruction of the viral envelope
4. Antibody-dependant cell-mediated cytotoxicity (ADCC) mediated by NK-like cells (see earlier for explanation)
Cells of the acquired immune system
Lymphocytes
Agranular leukocytes
20-40% of the circulating WBC
99% of the cells in lymphatic circulation
T (thymus-derived) cells
- Helper T cells: recognize antigen, help B cells to make antibodies and T cells to kill
- Cytotoxic T cells: poisonous to cells,kill cells infected by viruses and intracellular bacteria
B (bone marrow-derived) cells
- Make antibodies
- Have insoluble antigen-binding receptor on its surface. In fact have multiple clones of this receptor;
monoclonal antibodies
NK (natural killer) cells
- See earlier in notes

Each subset has distinct cell-surface molecules, e.g. CD4 on helper T-cell which is the receptor for HIV
molecules
Lymphocyte precursors are produced in the haematopoietic tissue in the bone marrow
4

MCD Immunology

Alexandra Burke-Smith

T cells are then transported to the thymus, where they undergo THYMAL EDUCATION. Here 95-99% get
destroyed as they have the potential to recognise host cells

4. Outline the role of clonal selection in immune responses.

Lymphocyte antigen receptors

B cell antigen receptor is a membrane-bound antibody, i.e. surface immunoglobulin which binds intact
antigens; recognises surface of protein, therefore antigen must be in native conformation
Expressed on the T cell surface are 2 protein chains (alpha and beta) which together make the t cell antigen
receptor (TCR). This binds to digested antigen fragments.
Each antigen receptor binds to an epitope on a different antigen, and is unique to a cell. There are many
copies of the receptor on the cell surface

The T-cell antigen receptor (TCR)


Recognizes complex of antigen peptide and HLA (MHC) molecule
HLA (Human leukocyte antigen) binds to little fragments of the pathogen, transports them to the surface so
they can be recognized, e.g. so a virus cannot hide inside a host cell. Combination of short peptide from
microorganism + HLA = recognition by TCR
MHC denotes the Major Histocompatibility Complex (also known as HLA)
Generation of clonal diversity in lymphocytes
During B and T cell development, random genetic recombinations occur within each cell among multiple
copies of immunoglobulin genes (B cells) or TCR genes (T cells). There are parallel genes, but they undergo
random splicing and recombination which leads to a large repertoire of antigen receptors
These processes generate the diversity of clones of lymphocytes: each clone is specific to a different antigen.
Primary Immune Response: clonal selection
A typical antigen is recognized by 1 in ~105 naive T cells
98% of T cells are in the lymph circulation and organs; 2% in blood.
Antigen binds to surface receptor on the B cell (Ig) or the T cell (TCR) and causes selective expansion of that
clone.
The receptors which bind with highest affinity to the antigen are selected for, outcompete the other
receptors , proliferate and survive to form effector lymphocytes
What happens when the antigen is removed?
Most lymphocytes that have proliferated recently will die after fulfilling their function
(involves 2 or 3 mechanisms)
Some survive as memory cells. These are epigenetically modified so that next time the
host is infected, the frequency of the receptors will increase.
How does the immune response clear a pathogen?
5

MCD Immunology

Alexandra Burke-Smith

Cytotoxic T lymphocytes (CTLs) kill cells infected by viruses or intracellular bacteria. It recognizes antigen
peptide and HLA complex, releases granules of enzymes including proteases which digest DNA. The cell is
therefore destroyed- APOPTOSIS
Antibodies bind to pathogens: the complex is destroyed or ingested by cells.

5. Understand the role of the physical organization of the immune system in its function.
How does a T cell meet its antigen?
Antigens are taken up by specialized ANTIGEN-PRESENTING CELLS (class of cells which are capable of taking
up particles, ingesting them and presenting proteins on their surface)
transported from the tissues into secondary lymphoid organs, where they meet T cells
initiate the acquired immune response
Antigen-presenting cells include B lymphocytes, macrophages and dendritic cells (which are most efficient)
Lymphoid Organs
Organized tissue in which lymphocytes interact with non lymphoid cells
Sites of initiation and maturation of adaptive immune responses.
Primary lymphoid organs produce the lymphocytes, e.g. bone marrow and thymus
Secondary lymphoid organs include lymph nodes, spleen, and mucosa-associated lymphoid tissue
(MALT)

Lymphocytes and antigen-presenting cells circulate continuously blood and lymphatic vessels from
tissues via lymph nodes/spleen into the blood
T cells spend around 1-2 hours in the blood, but the rest of the day in the lymph
The tissues are patrolled by lymphocytes, antibodies and antigen-presenting cells.
For example, the skin contains lymphatic vessels that drain into local lymph nodes.
Gut lymphoid tissue controls responses in the intestinal tract.
Antigens present in the blood are taken to the spleen.
6

MCD Immunology

Alexandra Burke-Smith

Definitions
Lymphocytes are mononuclear cells which are part of the leukocyte (white blood) cell lineage. They are subdivided
into B (Bone marrow-derived) and T (Thymus-derived) lymphocytes. Lymphocytes express antigen receptors on their
surface to enable recognition of a specific antigen
Nave lymphocytes have never encountered the antigen to which their cell surface receptor is specific and thus have
never responded to it.
Memory lymphocytes are the products of an immune response, enabling the specificity of their specific receptor to
remain in the pool of lymphocytes in the body.
Innate immunity An early phase of the response of the body to possible pathogens, characterized by a variety of nonspecific mechanisms (e.g. barriers, acids or enzymes in secretions) and also molecules and receptors on cells which
are Pattern Recognition Molecules which recognize repeating patterns of molecular structure found on the surface
of microorganisms. The innate immune response does not generate memory.
Adaptive immunity is the response of antigen-specific lymphocytes to antigen, and includes the development of
immunological memory. Adaptive responses can increase in magnitude on repeated exposure to the potential
pathogen and the products of these responses are specific for the potential pathogen. Also known as Specific
Immunity or Acquired Immunity.
Active Immunity is the induction of an immune response by the introduction of antigen.
Passive Immunity is immunity gained without antigen induction i.e. by transfer of antibody or immune serum into a
nave recipient.
Primary Response is the response made by nave lymphocytes when they first encounter their specific antigen.
Secondary Response is the response made by memory lymphocytes when they re-encounter the specific antigen.
T cells originate in the thymus. They recognize antigen presented at the cell surface by MHC/HLA molecules. Surface
markers on T cells are CD3, CD4 & CD8
B cells originate in the bone marrow. They recognize free antigen in the body fluids. Surface markers associated with
B cells are CD19, surface immunoglobulin class II MHC

MCD Immunology

Alexandra Burke-Smith

2. Immune Cells and Organs


Dr Keith Gould (k.gould@imperial.ac.uk)

Primary lymphoid organs (thymus & bone marrow) for production of lymphocytes
Secondary lymphoid organs help antigen to come into contact with lymphocytes expressing appropriate specific
receptors
Lymphocyte numbers are carefully regulated, and they recirculate
T cells express CD3, and recognise processed antigen presented by MHC molecules
B cells express CD19 and CD20, and recognise intact, free antigen
Important APC are dendritic cells, B cells, and macrophages

1. Name the primary and secondary lymphoid organs and briefly differentiate between their functions.
Primary lymphoid organs: organs where lymphopoeisis occurs, i.e. where lymphocytes are produced, including the
bone morrow and thymus to produce T and B lymphocytes.
Secondary lymphoid organs: where lymphocytes can interact with antigen and with other lymphocytes, including
spleen, lymph nodes, mucosal associated lymphoid tissues (MALT)

2. Draw simple diagrams to illustrate the structure of the thymus, lymph node, spleen, Peyers patch and
indicate the changes that occur after stimulation by antigen.
Primary lymphoid Organs:
Bone Marrow
- Site of haematopoesis, i.e.
generation of blood cells
- In an embryo, this happens in
amniotic sac
- In foetus, occurs in all bones, liver
and spleen. Marrow is also very
cellular
- In adults, this occurs mostly in flat
bones, vertebrae, Iliac bones, Ribs
and the ends of long limbs
Thymus
- Where maturity of T-cells occurs
- Bi- lobed
- Medulla and cortex regions
- No change during immune response to antigens, continuous development of T cells
8

MCD Immunology
-

Alexandra Burke-Smith

Hassalls corpuscle secretes soluble factors, and is important in regulatory T cells

Secondary Lymphoid Organs

Lymphatic System
Fluid drained from between tissue cells absorbed into lymph
2 to 3 litres of lymph are returned to the blood each day (via superior vena cava)
In the process of draining, lymph can capture pathogens
Fluid passes through lymph nodes which survey for pathogens
LYMPH NODES
Kidney shaped organs > 1cm
During immune response, swell in size
Fluid enters through AFFERENT vessel
Fluid leaves via EFFERENT vessel
Lymph perculates through all lymphocytes before
leaving the node
Usually a SUMMATIVE junction, i.e. there are many
afferent vessels but one efferent vessel
Rich blood supply lets lymphocytes into the lymph
nodes via the HIGH ENDOLTHELIAL VENUES
T-cell zone: parafollicular cortex
B-cell zone: lymphoid follicle- mostly on the
periphery of the lymph node
During immune response, there is a massive proliferation of B cells, which leads to the formation of a
GERMINAL CENTRE
Specific chemokines target their respective lymphocytes to their specific areas, e.g. T-cells to the
parafollicular cortex
The lymph entering lymph nodes may also contain cells such as dendritic cells and macrophages

Spleen
Filter for antigens in the blood
Large organ in the abdomen
Separated into
white pulp: lymphoid cells around blood vessels, full
of lymphocytes
red pulp: contains old damaged RBC
Any diseases involving RBC, i.e. sickle-cell, often
results in an enlargement of the spleen
T cell area: peri-arteriolar lymphatic sheath (PALS)
B cell area is located further away from blood vessels
Not a vital organ: Individuals who do not have a spleen are highly susceptible to infections with encapsulated
bacteria

Mucosal Associated Lymphoid Tissue (MALT)

Epithelium is the first line of defence


mucosae and skin form a physical barrier
very large surface area, in large part a single layer of cells
heavily defended by the immune system in case it breaks

MCD Immunology

Alexandra Burke-Smith

Gut Associated Lymphoid Tissue


-

Many villi, plus smoother regions


Involved in the mesenteric lymphatic drainage
system to mesenteric lymph nodes, including
intraepithelial lymphocytes
PEYERS PATCH: non-capsulated aggregation
of lymphoid tissue- predominantly B
lymphocytes and contain germinal centres
during immune responses
M-CELLS: sample contents of the intestine,
surveying for pathogens which they can then
deliver to immune cells

Cutaneous Immune System


- I.e. the skin
- Epidermis contains keratinocytes, Langerhans cells
and intraepidermal lymphocytes
- The dermis heavily guards the epidermis with
immune cells, e.g. macrophages, T lymphocytes etc
- The demis also consists of venules and lymphatic
vessels, providing entry to the blood circulation and
drainage to regional lymph node

3.

Outline the recirculation of lymphocytes.


PROBLEM:
There are a very large number of T cells with different
specificities
There are a very large number of B cells with different
specificities
There may only be limited amounts of antigen
How does the body ensure that the antigen meets
lymphocyte with specific receptor?
SOLUTION:

Lymphocyte recirculation
Pathogen on mucosal surface
Naive lymphocytes leave BM and Thymus and enter the bloodstream
Recirculate through peripheral lymphoid tissue
Recognition of antigen- massive B cell proliferation in secondary lymphoid tissue (lymphocyte activation)
Otherwise the lympcytes die
Extravasion of naive T cells into the lymph nodes (occurs during immune response)
The naive T cell rolls along the
epithelium
These are then stopped and
activated by specific chemokines at
a particular place on the
epithelium. This right place is
determined by SELECTINS
10

MCD Immunology
-

Alexandra Burke-Smith

INTEGRINS then increase adhesion of the T cell to the epithelium, leading to arrest of the cell
Transendothelial migration of the T cell from the bloodstream into the lymph node then occurs
Antigens also enter the lymph nodes via the draining lymphatics
Naive lymphocytes recirculate approx once per day -- enter lymph nodehigh endothelial venue
lymphocyte is activated by antigen stops recirculatng massive proliferation of B lymphocytes reenter
the blood via the superior vena cava (via the efferent vessel) target invading microbes/pathogens

Anatomical structure of the immune system

4. Explain the use of CD (cluster of differentiation) markers for discrimination between lymphocytes.
Lymphocytes
Small cells with agranular cytoplasm and a large nucleus
Can be subdivided into 2 groups depending on where they were produced
- B lymphocytes (Bone Marrow)
- T lymphocytes (Thymus)
These express different CD molecules, which are recognised by different antibodies
CD Markers
an internationally recognised systematic nomenclature for cell surface molecules
used to discriminate between cells of the haematopoietic system
more than 300 CD markers
clinical importance e.g. CD4 in HIV

5. Compare and contrast phenotypic characteristics of B and T cells.


Relative Quantities
T cells

B cells

7.5 x 10 in the blood


Blood contains 2% of the total pool, therefore
50 x 7.5 x 109 = 3.75 x 1011

~ 1012, but mostly in the gut

T Lymphocytes

all express CD3- antigen specific receptor (TCR)


TCR, about 10% in blood
TCR, about 90% in blood: ~2/3 express CD4, ~1/3 express CD8. All mature T cells express one or the other
CD4+ = T helper cells, regulatory T cells- Secrete cytokines
CD8+ = cytotoxic T cells- Lyse infected cells, secrete cytokines
Thymic output of naive T cells declines with age, and the thymus atrophies. Therefore older people have a
reduced ability to respond to new infections. However the total number of T cells does not change, there are
just more memory cells.
ANTIGEN RECOGNITION
only recognise processed antigen presented at the surface of another cell using T cell receptor
antigen is presented by an MHC molecule

B lymphocytes

Produced by and develop in bone marrow


Surface antigen receptor (B cell receptor) : immunoglobulin like molecule
Express CD markers CD19 & CD20 (not CD3, CD4 or CD8)
Express MHC Class II (can present antigen to helper T cells)
Effector function is to produce antibodies
ANTIGEN RECOGNITION
11

MCD Immunology

Alexandra Burke-Smith

recognise intact antigen free in body fluids (so


not presented by another molecule)
Use B cell receptor, a membrane anchored
form of antibody linked to signalling subunits

6. Give examples of antigen presenting cells (APCs)


and their locations.
Antigen presenting cells (APC)
cells that can present processed antigen (peptides) to T
lymphocytes to initiate an acquired (adaptive) immune response:
Dendritic cells (DC)
- Location: Widely spread e.g. Skin & mucosal tissue
- Presents to T cells
B lymphocytes
- Location: lymphoid tissue
- Presents to T cells
Macrophages (activated)
- Location: lymphoid tissue
- Presents to T cells
Follicular dendritic cells
- Location: lymph node follicles
- Presents whole antigens to B cells

12

MCD Immunology

Alexandra Burke-Smith

3. Innate Immunity
Dr Keith Gould (k.gould@imperial.ac.uk)

1. Briefly describe the functions of the important phagocytic cells: neutrophils, monocytes/macrophages.
2. Define cytokines and describe their general properties.
3. Define complement, list its major functions, and draw a simple diagram of the complement pathways.
4. Describe a typical inflammatory response to a localised infection involving recruitment of neutrophils, and
phagocytosis and killing of bacteria.
5. Briefly outline the events involved in a systemic acute phase response.
6. Outline the phenotype and functions of natural killer (NK) cells.
Innate Immunity

Present from birth- in built


Not antigen specific, but recognizes pathogen-associated molecular patterns (PAMP)
Not enhanced by second exposure, i.e. no memory (comes directly from lymphocytes)
Uses cellular and humoral components in body fluids
Rapid response, cooperates with and directs adaptive immunity

Phagocytosis

Phagocytic cells can ingest whole microorganisms, insoluble particles, dead host cells, cell debris and
activated clotting factors.
In the first step, there has to be adherence of the material to the cell membrane.
Finger-like projections called pseudopodia engulf the material, and a membrane-bound structure called a
phagosome is formed.
This then fuses with a lysosome to form a phagolysosome, mixing the contents of the lysosome with the
engulfed material.
Lysosomes contain hydrogen peroxide, oxygen free-radicals, and various hydrolytic enzymes which can
digest and break down the engulfed material.
Finally, any waste products are released from the cell.

Phagocytic Cells
Neutrophils
- (POLYMORPHONUCLEAR LEUKOCYTE)
13

MCD Immunology

Alexandra Burke-Smith

50-70% of leukocytes
short lived cells, circulate in blood then migrate into tissues; first cells to be recruited to a site of tissue
damage/infection
- ~1011 produced per day in a healthy adult, but this can increase approx ten-fold during infection
Macrophages
- less abundant
- dispersed throughout the tissues
- signal infection by release of soluble mediators
Neutrophils
To fight infection, neutrophils:
1. Migrate to site of infection (Diapedesis and Chemotaxis)
- Neutophil rolls along normal endothelium
- At site of damage/when antigen is presented by macrophage, a change in the nature of the endothelium
occurs
- Integrin activation by chemokines- This leads to a change in adhesion molecules into high affinity state- they
flatten out and undergo migration through endothelium
- Chemotaxis- directed migration along chemokine concentration gradient towards area of high concentration
2.
-

Bind pathogen- Opsonisation


Coating of pathogen with proteins to facilitate phagocytosis
Opsonins are molecules that bind to antigens and phagocytes
Antibody and complement function as opsonins
NEUTROPHIL BINDING TO OPSONINS

Bacterium-antibody complex complement activation Fc receptor on phagocyte binds to antibody, CR receptor


to complement opsonins bound to pathogen signal activation of phagocyte
3.
-

Phagocytose
Key component of host defence
May result in pus-filled abscess
Much more effective after OPSONISATION

4. Kill pathogen
- Neutrophil Killing Mechanisms
OXYGEN-INDEPENDENT
Uses enzymes:
- Lysozyme
- Hydrolytic enzymes

Uses antimicrobial peptides (defensins)

OXYGEN-DEPENDENT
Uses Respiratory burst: Toxic Metabolites
- Superoxide anion
- Hydrogen perozide
- Signlet oxygen
- Hydroxyl radical
Reactive Nitrogen Intermediates:
- Nitric oxide

Phagocyte Deficiency
Associated with infections due to extracellular bacteria and fungi
Bacteria
- Staphylococcus aureas
- Pseudomonas aeruginosa
14

MCD Immunology

Alexandra Burke-Smith

- Escherichia coli
Fungi
- Candida albicans
- Aspergillus flavus
Deep skin infections, impaired would healing
Poor response to antibiotics
E.g. chronic granulomas disease
Phagocytes

Monocytes
Circulate in blood
Smaller than tissue macrophages
Precursor to tissue macrophages
Macrophages
Express pathogen recognition receptors (e.g. toll-like receptors TLR, NOD-like receptors NLR, RIG-I: viral
genomes) for many bacterial constituents
Bacteria bind to macrophage receptors- initiate a response release of cytokine (soluble mediators SIGNAL
INFECTION)
Phagocytosis then occurs: Engulf and digest bacteria

Cytokines

Small secreted proteins


Cell-to-cell communication
Generally act locally
Powerful at low concentrations
Short-lived

INTERLEUKINS (IL-x)
Between leukocytes
approx 35 different types
INTERFERONS (IFN)
Anti-viral effects
approx 20-25 different types
CHEMOKINES
Chemotaxis, movement
approx 50 different types
GROWTH FACTORS
development of immune system
CYTOTOXIC
Tumor necrosis factor (TNF)

Mechanism

Inducing stimulus transcription of gene for soluble protein in cytokine-producing cell cytokine binds to
receptor on target cell -- Binding generates signal changes in gene transcription and gene activation
biological effect
Cytokines are usually released in a mixture, therefore have a wide range of effects on a range of different
target cells

15

MCD Immunology

Alexandra Burke-Smith

Autocrine Action
same cell
e.g. Interleukin 2
Paracrine Action
nearby cell
e.g. interferon
Endocrine action
circulate in bloodstream distant cell
e.g. interleukin 6
Important Cytokines
IL-1
alarm cytokine
fever
TNF-
alarm cytokine
IL-6
acute phase proteins
liver
IL-8
chemotactic for neutrophils
IL-12
directs adaptive immunity
activates NK cells
Bacterial Septic Shock

Systemic infection
Bacterial endotoxins cause massive release of the TNF- and IL-1 by activated macrophages
Increased vascular permeability
Sever drop in blood pressure
10% mortality

Dendritic Cells

Network of cells located at likely sites of infection, in the skin and near mucosal epithelia
Recognise microbial patterns, secrete cytokines
engulf pathogens, and migrate to local lymph node to present antigens to adaptive immune system

Complement
describe the activity in serum which could complement the ability of specific antibody to cause lysis of bacteria
Ehrlich (1854-1915)

major role in innate and antibody-mediated immunity


complex series of ~30 proteins and glycoproteins, total serum conc. 3-4 mg/ml
triggered enzyme cascade system; initially inactive precursor enzymes, and as a few enzymes are activated,
they catalyse the cleaving of secondary components etc
rapid, highly amplified response
very sensitive
components produced mainly in the liver, but also by monocytes and macrophages
16

MCD Immunology

Alexandra Burke-Smith

Activation
The Classical Pathway
initiated by antigen-antibody complexes
The Alternative Pathway
direct activation by pathogen surfaces
The Lectin Pathway
antibody-independent activation of Classical Pathway by lectins which bind to carbohydrates only found on
pathogens, e.g. MBL and CRP

Classical & Alternative Pathways converge at C3


C3 leads to the final Common Pathway
late phase of complement activation
Ends with the formation of the Membrane Attack Complex (MAC)
As a bi-product of the classical pathway, fragments cleaved are
pro-inflammatory molecules
Principle opsonin is C3b

Control Mechanisms
Acheieved by:
Lability of components, i.e. their short half-life
Dilution of components in biological fluids
Specific regulatory proteins:
- Circulating/soluble, eg C1-inhibitor, Factor I, Factor H, C4-binding protein
- membrane bound, eg CD59 (interferes with MAC insertion) and DAF (competes for C4b)
Function
1. Lysis
2. Opsonisation
3. Inflammation/chemotaxis
Mast Cells

Secrete histamine and other


inflammatory mediators,
including cytokines
Mucosal mast cell
lung
Connective tissue mast cells
skin and peritoneal cavity
near blood vessels
Recognise, phagocytose and kill bacteria
activated to degranulate by complement products (ANAPHYLATOXINS) leading to vasodilation and increased
vascular permeability.
Local Acute Inflammatory Response
17

MCD Immunology

Alexandra Burke-Smith

tissue damage trigger cascades:

invasion of pathogens recognition by macrophages phagocytosis release of soluble cytokines +


chemokines Diapedesis and Chemotaxis (slowing down of neutrophils in blood vessels and migration
towards site of infection)
complement activation mast cell degranulates release of pro-inflammatory fragments + histamines
endothelial damage change in nature of endothelium signals site of infection to neutrophils

Systemic Acute-Phase Response


May accompany local inflammatory response 1-2 days after
Fever, increased white blood cell production (LEUKOCYTOSIS)
Production of acute-phase proteins in the liver
Induced by cytokines
ACUTE PHASE PROTEINS
Required to enhance immune response
C-reactive protein (CRP)
- C polysaccharide of pneumococcus
- Activates complement
- Levels may increase 1000 fold
Mannan Binding Lectin (MBL)
- Opsonin for monocytes
- Activates complement
Complement
Fibrinogen
- clotting
Importance of Cytokines
Signal liver:
- produce acute-phase proteins
Signal bone marrow:
- Increase Cerebrospinal fluid (CSF) by stromal cells and macrophages
- Increase leukocytosis (WBC production)
Signal Hypothalamus:
- Prostaglandins production fever
- Via pituitary gland and adrenal cortex, release corticosteroids signals liver again

Natural Killer (NK) cells

Large granulated lymphocytes


Cytotoxic: lyse target cells ad secrete INTERFERON-
5-10% peripheral blood lymphocytes
No antigen-specific receptor
Complex series of activating and inhibitory receptors
Have receptors which bind to antibody-coated cells (ADCC- ANTIBODY DEPENDENT CELL-MEDIATED
CYTOTOXICITY)
Important in defence against tumour cells and viral infections, especially Herpes

Target Cell Recognition

Missing self recognition


Ligation of inhibitory NK receptors = inhibition of target cell killing
Involves recognition of lack of MHC molecules
Induced self recognition
Ligation of activating NK receptors = target cell killing
Involves stress-induced molecules
18

MCD Immunology

Alexandra Burke-Smith

4. Antibodies
Dr Keith Gould (k.gould@imperial.ac.uk)

1. Describe with the aid of a simple diagram the immunoglobulin molecule, identifying the antigen-binding site (Fab)
and Fc portions of the molecule.
2. Briefly describe the properties of the antigen-binding site.
3. Distinguish between antibody affinity and avidity.
4. List the immunoglobulin classes and sub-classes in man. Describe their functions and relate these to their
individual structure.
Overview
What is an antibody?
A protein that is produced in response to an antigen
Binds specifically to the antigen
Form the class known as IMMUNOGLOBULINS
Large family of soluble GLYCOPROTEINS
Produced by B lymphocytes
Found in serum
>107 different types
Deficiency is life threatening
After binding antigen, initiate secondary effector functions
- Complement activation
- Opsonisation
- Cell activation via specific antibody-binding receptors (Fc receptors)
Structure
symmetrical
Two light (25kDa) chains, two heavy (50kDa) chains
Each chain has amino and carboxyl terminal
Chains heald together by disulphide bridges
Electrophoresis of globulins found in serum:
- Relative amounts (decreasing): A, , ,
- Electrophoretic mobility- towards +ve electrode: A, ,
,
Different antibodies therefore have different charges
The discovery of antibody structure
Rodney Porter
Limited the digestion of gamma-globulin with purified
papain, which produced 3 fragments in equal amounts
2 fragments had antigen binding activity (Fab)
The third did not, but formed protein crystals (Fc)
Flexibility
There is a hinge in the antibody which allows flexibility
between the two Fab

19

MCD Immunology

Note:

Alexandra Burke-Smith

This allows the angle between the two antigen binding sites to change
angle depending on the proximity of cell surface determinants, i.e.
how close together antigens are

Both light and heavy chains can be divided into variable (where the
sequences are different) and constant (same sequence) regions
Each IG (immunoglobulin/antibody) domain, e.g. variable light, has
INTRAMOLECULAR DISULPHIDE BONDS to maintain their specific 3D
structure required for antigen binding
Many cell surface proteins also have IG-like domains, and are said to belong to the IG super family
The constant region binds to Fc receptors, which can lead to cell activation, e.g. NK cells (secondary effector
functions in immune response)

Antigen-binding site

Antigen binding occurs at 3 HYPERVARIABLE regions, known as COMPLEMENTARITY DETERMINING REGIONS


(CDRs)
These have specific residue positron numbers
The region of binding is a large undulating 3D structure (~750A = 10-10m), so is highly specific and there are a
significant number of interactions between the antibody and antigen surface

Forces involved
Hydrogen bonds
Ionic bonds
Hydrophobic interactions
Van der Waals interactions
Are non-covalent, therefore are relatively weak. This means that in order to have a HIGH AFFINITY, there can only be
a short distance between the antigen and antibody, highly complementary nature, and a significant number of
interactions.
Antibody Affinity
The strength of the total non-covalent interactions between a single antigen binding site and a single epitope on the
antigen.
The affinity association constant K can be calculated:
K varies from 104 to 1011 L/mol

Antibody Avidity
The overall strength of multiple interactions between an antibody with multiple binding sites and a complex antigen
with multiple epitopes

This is a better measure of binding capacity in biological systems


Monovalent interactions have a low affinity
Bivalent interactions have a high affinity
Polyvalent interactions have a very high affinity

Cross-Reactivity
Antibodies elicited in response to one antigen can also recognise a different antigen, for example:
1. Vaccination with cowpox induces antibodies which are able to recognise smallpox
20

MCD Immunology

Alexandra Burke-Smith

2. ABO blood group antigens are glycoproteins on red blood cells. Antibodies made against microbial agents on
common intestinal bacteria may cross-react with the glycoproteins, which poses a problem for blood
transfusions.
Isotypes and Allotypes
Isotypes are antibodies who are present in everybody, with a constant region.
Allotypes are antibodies that contain single amino acid mutations, giving allelic polymorphisms which vary in
the population
Immunoglobulin Classes
Different classes of antibodies differ in the constant regions of their heavy chains
Class
IgG
IgA
IgM
IgD
Heavy chain

CH Domains
3
3
4
3
Light Chain
/
/
/
/
IgG and IgA have subclasses
Class
Subclass
H chain

IgG
IgG1, IgG2, IgG3, IgG4
1, 2, 3, 4

IgG
heavy chain
most abundant
monomer
4 subclasses- variability mainly
located in hinge region and
effector function domains
Actively transported across the
placenta- protection from
mother to newborn
Found in Blood and
extracellular fluids
Major activator of classical
complement pathway (mainly
IgG1 and IgG3)
Subclasses decrease in
proportion from 1-4

IgA
IgA1, IgA2
1, 2

IgA
heavy chain
Second most abundant
monomer (blood)
dimer (secretions)
Major secretory
immunoglobulin
Protects mucosal surfaces from
bacteria, viruses and protozoa
Secretory IgA: joined by J chain
and secretory component.
Plasma cell secretes dimeric
form without secretory. This
bonds to poly-Ig receptor and is
endocytosed and secreted into
lumen. The poly-Ig receptor is
cleaved and becomes the
secretory component

IgE

4
/

IgM
heavy chain
pentameric
5 monomers joined by J chain
(10 x Fab)
mainly confined to blood
(80%)
first Ig synthesised after
exposure to antigen (primary
antibody response)
multiple binding sites
compensate for low affinity
efficient at agglutination of
bacteria
activates complement

The secretory component


protects IgA from being
degraded in the lumen, by
proteases etc

IgD
heavy chain
extremely low serum concentrations
least well characterised
surface IgD expressed early in B cell
development
involved in B cell development and activation

IgE
heavy chain
present at extremely low levels
produced in response to parasitic infections and
in allergic diseases
binds to high affinity Fc receptors of mast cells
and basophils
21

MCD Immunology

Alexandra Burke-Smith

cross-linking by antigen triggers mast cell


activation and histamine release

Selective Immunoglobulin Distribution

IgG and IgM in blood


IgG in extracellular fluid
Dimeric IgA in secretions across epithelia, including breast milk
Maternal IgG in foetus via placental transfer
IgE with mast cells below epithelium
Brain devoid of antibodies

Antibody effector functions

Effector Function

Activity

Example

Neutralization of toxins
Neutralization of viruses
Neutralization at body
surfaces
Agglutination

Inhibits toxicity
Inhibits infectivity
Inhibits infectivity of
bacteria & viruses
Ag-Ab complexes/
Lattice formation
Promotes
phagocytosis
Classical Pathway

Tetanus toxin
Measles
Polio
Salmonella
Bacteria & RBC

Antibody
Class
Mainly IgG
Mainly IgG
Secretory
IgA
IgM, IgG

Bacteria, fungi

IgG

Ag-Ab complex

IgM, IgG

Parasites
Pollen
Virus infected
cells

IgE

Opsonization
Complement activation

Mast Cell sensitisation & Expulsion


triggering
Hypersensitivity
NK cell
Cytotoxicity
ADCC

Mainly IgG

Summary
Antibodies:
In defence
- targeting of infective organisms
- recruitment of effector mechanisms
- neutralisation of toxins
- removal of antigens
- passive immunity in the new born
In medicine
- levels used in diagnosis and monitoring
- pooled antibodies for passive therapy/protection
In laboratory science
- vast range of diagnostic and research applications

22

MCD Immunology

Alexandra Burke-Smith

5. B Lymphocytes
Dr Ingrid Muller (i.muller@imperial.ac.uk)

1. Describe the process of stimulation of individual B cells to divide and secrete antibody such as to generate
immunity to a particular antigen (clonal selection)
2. Briefly outline the principles of immunoglobulin (Ig) gene rearrangement in the generation of diversity
3. Outline the differences in antibody production during primary and secondary immune responses
4. Differentiate between monoclonal and polyclonal antibody
Adaptive Immune response

B lymphocytes operate during the adaptive immune response


Develops after encounter of antigem
Takes 4-7 days to develop and become effective
Elicited antibody production specific to encountered antigen
2 types:
Humoral- B cells -- antibodies
Cell Medicated- T cells -- cytokines, lysis of pathogens

B Lymphocytes

White blood cells


Derived from haemopoietic stem cells
Are effector cells of humoral immunity; they secrete antibodies and form memory cells

Where do they come from?


Derived in the bone marrow in the absence of antigens
Mature in the bone marrow, whereby they express specific B cell receptors (BCR)
Migrate into the circulation (blood, lymphatic system) and into lymphoid tissues
Antibody production requires antigen-induced B cell activation and differentiation- this occurs in peripheral
lymphoid organs
B cell Maturation
Pro-B Cell Pre-B Cell Immature B Cell Mature B Cell
Occurs in the bone marrow in the absence of antigen
Mature B cells are specific for a particular antigen- their specificity
resides in B cell receptor (BCR); a membrane bound immunoglobulin
B cell Receptor (BCR)
Transmembrane protein complex composed of:
mIg
- central larger immunoglobulin molecule
- cytoplasmic tail too short so is not involved in signalling
Ig/Ig
- di-sulfate linked heterodimers
- contain immunoglobulin-fold structure
- cytoplasmic tails of Ig/Ig is long enough to interact with intracellular
signalling molecules
has a unique binding site- binds to ANTIGENIC DETERMINANT or
EPITOPE -made before the cell ever encounters antigen
large monoclonal population on surface of the B lymphocyte
23

MCD Immunology

Alexandra Burke-Smith

Antigen and BCR diversity


For the immune system to respond to the large number of antigens we are exposed to, we need to have a
large REPERTOIRE of specific BCR on different B cells that can recognise the huge array of antigens
1010 different antibody molecules can be generated by B cells with specific BCR
Functional BCR genes do not exist until they are generated during lymphocyte development
Each BCR chain ( & light chains, and heavy chain) is encoded by separate MULTIGENE FAMILIES ON
DIFFERENT CHROMOSOMES
During maturation, these gene segments are rearranged and brought together to form the BCR
IMMUNOGLOBULIN GENE REARRANGEMENT
There are a number of VARIABLE; V, DIVERSITY;D and JOINING;J gene segments that may be responsible for
each chain. The Diversity segment is only associated with the heavy chain. There is also a CONSTANT REGION
associated with each chain
This generates the diversity of the lymphocyte repertoire
Prototypical Membrane Protein Synthesis
Genomic DNA (transcription) Primary transcript RNA/pre-mRNA (Splicing) Mature mRNA
(translation) Membrane protein
Intracellular; Amino terminus of protein and protein domains relating to specific exons
Transmembrane; relates to specific exon/s
Extracellular; cytoplasmic tail- consists of exons and carboxyl terminus
Light Chain Synthesis
Germline DNA (rearrangement of V and J segments involving VDJ RECOMBINASE) B cell DNA
(Transcription) Primary transcript RNA/pre-mRNA (Splicing) Mature mRNA (translation) Light chain
polypeptide (Kappa or Lamda)
During joining of gene segments the unused DNA is looped out and removed (Germline DNA B cell DNA)
Heavy Chain Synthesis
Germline DNA (rearrangement of V and J segments involving VDJ RECOMBINASE) B cell DNA
(Transcription) Primary transcript RNA/pre-mRNA (Alternative Splicing) Mature mRNA (translation)
Heavy chain polypeptide
ALTERNATIVE SPLICING; results in different mature mRNA, as the mRNA express different genes (e.g. they
may have different constant region genes present)
BCR rearrangement
Required for B cell maturation

Adaptive Immune Response

Antibody production is a highly regulated process after activation by epitope


If a B cell does not meet an antigen death
24

MCD Immunology

Alexandra Burke-Smith

Antibodies may keep specificity but change


class
During immune response, the first antibody
produced is IgM, but this can change
The adaptive immune response is characterised
by:
1. Specificity
2. Diversity
3. Memory

Clonal Selection
Basis of adaptive immunity
Non-self reactive mature lymphocytes then
migrate to the periphery
Our immune system is usually exposed to multiple antigens, therefore multiple cells will be activated
Each lymphocyte (T or B) expresses an antigen receptor with a unique specificity,
Binding of antigen to its specific receptor leads to activation of the cell, causing it to proliferate into a clone
of cells
All of these clonally expanded cells bear receptors of the same specificity to the parental cell
Lymphocytes expressing receptors that recognize self molecules are deleted early during lymphocyte
development and are phagocytosed/lysed
Result: Plasma Cells, Antibodies, Memory cells
Antibody production
Naive antigen-specific lymphocytes cannot be activated by antigen alone; they require accessory signals
either from:
- Microbial Constituents- Thymus Independent
- Helper T cells- Thymus Dependent

Thymus Independent
Microbial Consistuents
Only IgM is produced
No memory cells formed
Antigens directly activate B cells without the
help of T cells
This can induce antibodies in people with no
thymus and no T cells (Di-George syndrome)
The second signal required is either
provided by the microbial constituent or by
an accessory cell

Thymus Dependent
Helper T cells
All Ig-classes produced
Memory is formed
Membrane bound BCR binds with antigen
and is internalised and delivered to
intracellular sites
Antigen is degraded into peptides
Peptides associated with Self- MHC Class II,
forming a complex which is expressed at
the cell surface
T lymphocytes with a complementary T cell
receptor (TCR) recognises the complex
T helper cells then secrete LYMPHOKINES
B cell then enters the cell cycle, forming a
clone of cells with identical BCRsdifferentiating into plasma and memory
cells

T-B cell collaboration


Antigen cross link with BCR induces signal 1-- MHC II, B7
Antigen is internalised and degraded, and the peptide-MHC II complex is presented

25

MCD Immunology

Alexandra Burke-Smith

T cell recognises complex and co-stimulation by B7and CD28 interaction activation of T cells
B7(expressed by B cell)
CD28(expressed by TH cell)
Activated T cell expresses CD40L
The interaction between CD40L and CD40 (expressed by B cell) induces signal 2
Activated B cells (CENTROBLAST) express cytokine receptors
T cell derived cytokines bind to receptors on B cells
B cells proliferate and differentiate into antibody secreting plasma cells

Cytokines
Certain cytokines help to produce certain Ig classes during differentiation of CENTROCYTES into plasma cells

Class switching
During class switching, the variable region (and hence the specificity) remains constant
However the constant region changes from the original IgM

26

MCD Immunology

Alexandra Burke-Smith

Example of Ig class switching above


Immunological Memory

Consequence of clonal selection and antigen recognition


Memory responses are characterised by a more rapid, heightened and more efficient immune reaction that
serves to eliminate pathogens fast and prevent diseases
Can confer life-long immunity
Initial antigen contact induces a PRIMARY RESPONSE
Subsequent encounter with the same antigen will induce a SECONDARY RESPONSE which is more rapid and
higher
The secondary response reflects the activity of the clonally expanded population of MEMORY B CELLS
The primary response consists of mainly IgM, whereas the secondary response will involve other Ig classes
Immunological memory forms the basis for immunisation
B cell memory: Increase in antibody amount and antigen affinity

Property
Responding B cell
Lag period
Time of peak response
Magnitude of peak antibody
response
Isotype produced
Antigens
Antibody affinity

Primary Response
Naive
4-7 days
7-10 days
Varies depending on antigen

Secondary Response
Memory
1-3 days
3-5 days
100-1000x greater

Predominantly IgM
Thymus independent and
thymus dependent
Lower

Predominantly IgG
Thymus dependent
higher

Polyclonal and Monoclonal antibodies

Polyclonal antiserum- all antigenic epitopes induce an immune response many different B cells activated
different antibodies produced
Invading microorganisms have multiple antigenic epitopes A mixture of antibodies directed to several
antigenic determinants will be produced which are derived from many different clones of B cells = polyclonal
response
Monoclonal antibodies are derived from a single B cell clone, which can be extracted after first combining
the plasma cells with myeloma cells to form hybridomas. Monoclonal antibodies are used to quantify CD4
count in HIV patients

27

MCD Immunology

Alexandra Burke-Smith

Myeloma = cancerous plasma cells that divides permanently without antigenic stimulation and secretes
antibodies which are indistinguishable from normal antibody = myeloma proteins. They confer immortality
when hybridised with another cell
Plasmacytoma - clone of malignant plasma cells

28

MCD Immunology

Alexandra Burke-Smith

6. T lymphocytes and Antigen recognition


Dr Keith Gould (k.gould@imperial.ac.uk)

1. Outline the origins and functions of T lymphocyte subsets.


2. Briefly describe the structure and distribution of major histocompatibility complex (MHC) class I and class II
molecules.
3. Outline the mechanisms by which antigen presenting cells (APCs) process and present antigens.
4. Compare and contrast antigen recognition by B and T lymphocytes and by CD4+ and CD8+ T lymphocytes
T lymphocytes

Destroy intracellular pathogens


T cell receptor (TCR) recognizes small peptide fragment of antigen presented by MHC molecule on the
surface of host infected cell

T cell receptor (TCR)


Analogous to membrane bound Fab portion of antibody
The variable region is towards the N terminus
The constant region is towards the membrane
The cytoplasmic tail is too short for signaling, so the polypeptides associate
with CD3 POLYPEPTIDES with longer CYTOPLASMIC DOMAINS- this is critical
for signaling.
CD3 polypeptides may consist of GAMMA, DELTA, EPSILON and ZETA subsets
Antigen Recognition
2 major populations of T cells:
- CD4+: use CD4 co-receptor, see peptides on MHC class II- class II restricted
- CD8+: use CD8 co-receptor, see peptides on MHC class I- class I restricted
CO-RECEPTOR molecules bind to the relavent MHC, increasing the avidity of T CELL-TARGET CELL
INTERACTION
Important in signalling
Target Cell Destroying
CD8 (Tc or CTL)
- most are cytotoxic and kill target cells - also secrete cytokines
- Induce apoptosis in the target cell (programmed cell death, suicide)
CD4 (T helper cells, Th)
- secrete cytokines
- Recruit effector cells of innate immunity
- help activate macrophages
- Amplify and help Tc and B cell responses
MHC molecules present antigen fragments at cell surface
CD8+ CTL- kill target cells, e.g. viruses
CD4+ TH1- activate macrophages
CD4+ TH2- amplify antigen-specific B cell response

29

MCD Immunology

Alexandra Burke-Smith

The Thymus

Full of lymphocytes, but no immune response to infection


T cell precursors; PROGENITOR CELLS, develop in the bone marrow and migrate towards the thymus in the
circulation
Maturation of the Thymocytes occurs from the CORTEX to the MEDULLA
Mature THYMOCYTES/T cells then are transported out of the thymus and around the body via the circulation

Development
1. T cells are CD4- and CD8- (they express neither; double negative)
2. In the cortex, the T cells express a TCR precursor (pre TCR; + surrogate TCR)
3. In the medulla, ~1010 different TCRs created by gene rearrangements. The generated TCRs will only
express either CD4 or CD8
Due to these random gene rearrangements, many of the generated T cells will be SELF-REACTIVE,
therefore these must be destroyed

Selection
Occurs during interaction with macrophages and dendritic cells within the thymus. Only useful cells leave the
thymus.
Pre TCR checkpoint
- Is the new chain functional?
- No: Death by APOPTOSIS
- Yes: Survival and development to CD4+ CD8+ TCR+
Post TCR checkpoint
- Is the TCR functional?
- Is the TCR dangerous/autoreactive?
- Useless: cannot see MHC die by apoptosis
- Dangerous: see self, i.e. host molecules receive signal to die by apoptosis, i.e. NEGATIVE SELECTION
- Useful: binds weakly to MHC molecule receive signal to survive, i.e. POSITIVE SELECTION
- Note: only 5% of thymocytes survive selection

30

MCD Immunology

Alexandra Burke-Smith

Major Histocompatibility Complex (MHC)


Discovery
Tumour propagation in mice, i.e. tissue transplants
-acceptance = HISTOCOMPATIBLE
- rejection = HISTOINCOMPATIBLE
Inbred mouse strains - all genes are identical
Transplantation of skin between strains showed that rejection or acceptance was dependent upon the
genetics of each strain
Skin from an inbred mouse grafted onto the same strain of mouse = acceptance
Skin from an inbred mouse grafted onto a different strain of mouse = rejection
Transplantation antigens: MHC Class I
Gene mapping of the same locus shows second class of MHC molecule. This controls the ability to mount an
antibody response; celled IMMUNE RESPONSE GENE- MHC class II
Overview
Group of tightly linked genes important in specific immune
responses
Found in all vertebrates
Present antigens to T lymphocytes
MHC Class I
Consists of two NON-COVALENTLY ASSOCIATED
polypeptide chains:
- Heavy; 1, 2 3 these are transmembrane
polypeptides with a peptide binding, immunoglobulin like
and cytoplasmic region
- Light; 2-microglobulin this only consists of an
immunoglobulin like region
1 and 2 are joined by PEPTIDE BINDING GROOVE

CD8 interacts with the alpha-3 domain

MHC Class II
Consists of 2 transmembrane polypeptides of equal
length
Each polypeptide (alpha and beta) have two domains
CD4 interacts with the beta-2 domain
Cleft Geometry
MHC class I
- accommodate peptides of 8-10 amino acids
- Peptide buried within structure
- Peptides all same length
MHC class II
- accommodate peptides of >13 amino acids
- peptides stick out from MHC molecule
individuals have relatively few MHC, but need to present many peptides, so present SUBSETS of peptides
using BINDING MOTIFS
BINDING POCKET: certain residues (anchor residues) are directly associated with the peptide due to their
specific sequence
Binding pockets are useful in order to predict which peptides will be presented
31

MCD Immunology

Alexandra Burke-Smith

Human Leukocyte Antigens (HLA)


Human MHC molecules
Base DNA sequence- 3.6 million
128 functional genes, only 40% immunerelated

Gene expression
Polygenic: there are several gene loci
Co-dominant: both paternal and maternal MHC expressed
MHC Class I: present in nearly all nucleated cells, and levels may be altered during infection or by cytokines
MHC Class II: normally only on professional APC, and may be regulated by cytokines
Polymorphism
Large number of alternative different versions of the same gene within the population- termed an ALLELE
Each group of MHC alleles linked on one chromosome is termed MHC HAPLOTYPE
Different MHC Haplotypes lead to different immune responsiveness
>4200 HLA proteins in human population
Most polymorphic: Class I- HLA B, Class II- HLA DR
In reality MHC alleles are NOT randomly distributed in the population: some alleles are much rarer than
others, and alleles segregate with race.
This poses a problem for tissue transplants tissue typing
Antigen Processing and Presentation

T lymphocytes recognize only processed antigens presented on cell surfaces by MHC molecules
ENDOGENOUS antigen: synthesised within cell (taken to CD8)
EXOGENOUS antigen: synthesised outside the cell, and can be taken up by macrophage etc (taken to CD4)
Antigens in different locations require different responses
Different pathways present antigens from
different locations to different T cell
CLASS II
CLASS I
subsets

Class 1:
- Antigen cleaved by proteasome, taken
TAP
into RER by TAP (transporter associated
TRANSPORTER
with antigen presenting)
ASSOCIATED
WITH ANTIGEN
- Bind with MHC class I
PROCESSING
- Shaperones, e.g. calnexin, help protein
folding
- Then trafficked by golgi to surface
Class 2:
- Antigen endocytosed
- Cleaved by proteases
- MHC II migrates into RER- associates with INVARIANT chain
- The MHC II invariant complex is migrated into the golgi in ENDOSOME
- Invariant chain is digested by CLIP (Class II associated invariant chain peptide)
- CLIP is then exchanged for the antigenic peptide, which is then presented at the surface

CLIP
CLASS II
ASSOCIATED
INVARIANT
CHAIN PEPTIDE

32

MCD Immunology

Alexandra Burke-Smith

7. Effector T-lymphocytes
Dr Ingrid Muller (i.muller@imperial.ac.uk)

1. Outline the importance of antigen presenting cells in the induction of T lymphocyte responses
2. Describe effector functions of T lymphocytes including cell-mediated cytotoxicity, macrophage activation, delayed
type hypersensitivity and T/B lymphocyte cooperation
3. Briefly outline the function of T helper cells in relation to the cytokines they produce
4. Explain the different requirements for activation of naive and memory T lymphocytes

T-cell mediated immunity

Different pathogens require different immune defence strategies (intra/extracellular bacteria, virus,
parasites, worms and fungi)
Detects and eliminates intracellular pathogens
Eliminates altered cells, i.e. tumour cells
Location of antigen determines immune response:
o Phagocytes with ingested microbes microbial antigens in vesicles CD4+ effector T cells (TH 1)
o Infected cell with microbes in cytoplasm CD8+ T cells (CTLs)
CD4+ cytokine secretion macrophage activation killing of ingested microbes (also leads to
inflammation)
CD8+ killing of infected cell
CD4+ produce IFN-, IL-2, TNF-
CD8+ secrete granules

Naive T-lymphocytes

Activated in secondary lymphoid organs


Lymphocytes re-circulate in the blood lymph
lymphoid organs
Enter lymph node through specialized areas in postcapillary venues called HIGH-ENDOTHELIAL VENUES (HEV)
Advantage: recirculation increases likelihood to encounter
antigen
Only effector cells can enter non-lymphoid tissue (not
naive T cells) as they have to have undergone
differentiation process in response to antigen
Naive T cells migrate through secondary lymphoid organsthis is mediated by receptors on recirculating cells
Encounter with antigen in secondary lymphoid organs activate naive T cells
The migration of naive and effector/memory T cells differs
Dendritic cells, macrophages and B cells are all professional ANTIGEN PRESENTING CELLS (APC) they all
have MHC Class II molecules and lead to the activation of T cells into effector cells
1. Immature DC take up antigen (INNATE IMMUNITY) in the peripheral tissues
2. Immature DC activated leave tissue migrate to secondary lymphoid tissue
3. In the lymph node, the DC matures expresses high levels of peptide/MHC complexes and COSTIMULATORY
molecules therefore leads to more efficient APC

33

MCD Immunology

Alexandra Burke-Smith

Induction and Effector Phases of CMI


Initial Activation

T cells enter HEV in cortex


T cells monitor for antigens presented by APC:
encounter proliferation and differentiation into
EFFECTOR CELLS
non-encounter leave lymph nodes
Both antigen and costimulation is required for T-cell
activation
Costimulatory molecules e.g. CD28 (requires CD80
or CD86 ligand)
Lack of costimulation unresponsive T cells and
can lead to tolerance in peripheral T cells

After Recognition and Costimulation

Recognition proliferation/differentiation
effector function
T-cells secrete IL-2 and IL-2 receptor (required for
proliferation); DIRECT RESPONSE = AUTOCRINE
ACTION
This leads to the cell activation and multiplication
Effector function: APOPTOSIS- destroy infected target cell
Effector T cells are less dependent on costimulation

Resting T-cell: moderate affinity receptor (IL-2R + chains only)


Activated T-cell: high affinity receptor ( + + chains) and secretion
Binding of IL-2 and its receptor signals the T cell to enter the cell, which induces proliferation

IL-2

DEFINITIONS
Nave T cells: mature recirculating T cells that have not yet encountered antigen
Effector T cells: encountered antigen, proliferated and differentiated into cells that participate in the host defense
Target cells: Cells on which effector T cells act

T-effector cells
CD8: peptide + MHC class I- cytotoxic cells
CD4: Th1 cells- interact with macrophages- phagocytosis intracellular bacteria
Th2 cells interact with antigen-specific cell antibody production
CTLs

Naive T cell = CTLp


CTLp is essential a precursor, and must differentiate before it can kill
CTLp does not express IL-2 receptor
Require helper T cells for activation and proliferation (Th1)
34

MCD Immunology

Alexandra Burke-Smith

When binding to their specific antigenic peptide:self-MHC complexes, TCRs and their associated coreceptors
cluster to the site of cell-cell contact.
Clustering of TCRs then signals a reorientation of the cytoskeleton that POLARIZES the effector cell to focus
the release of effector molecules at the site of contact with the target cell.
CTLs contain lytic granules which contain cytotoxic molecules. In the polarized T cells the secretory
apparatus becomes aligned toward the target cell and the content of the lytic granules is secreted.
The lytic granules induces APOPTOSIS
CTLs can kill multiple targets
Early apoptosis: chromatin becomes condensed
Late apoptosis: nucleus very condensed, mitochondria visible, cell loses much of cytoplasm and membrane

Granules
PERFORIN: polymerises to form pore of Target cell
GRANZYMES: serine proteases, activate apoptosis in cytoplasm
GRANULYSIS: induce apoptosis
Cell Death

Granule Exocytosis Pathway


Perforin Granzymes Cascades
FAS Pathway
Interaction expression of Fas ligand
on T cell binding initiates cascades
apoptosis

CTL are re-used after dissociation with target


cell
Cytotoxicity

Apoptosis characterised by
fragmentation of nuclear DNA
CTL store PERFORIN, GRANZYMES, GRANULYSIN
Granules released after target recognition
Also release of soluble mediators that contribute to host defence:
- IFN- ; inhibits viral replication and activates macrophages
- TFN and TNF synergise with IFN-

TH cells

The type of TH activated depends on environment e.g. APC and cytokines


The signals the precursors receive correspond to the type of TH: IL-12 TH1 and IL-4 TH2
TH1 and TH2 correspond to MHC II
TH1 activate macrophages in a very regulated and coordinated manner and are involved in opsonisation and
phagocytosis - involving IFN-
TH2 coordinate mast cell degranulation involving IL-4 and release IL-5 eosinophil activtion

35

MCD Immunology

Alexandra Burke-Smith

TH cells coordinate immune


responses to infections with
intracellular pathogens
Cytokine mediated interactions
are also very important
T Helper subset differentiation,
cytokine profile and effector
functions

SEE POWERPOINT FOR MORE DIAGRAMS

Delayed Type Hypersensitivity (DTH) reaction

Mediated by pre-existing antigen specific T cells, mainly by Inflammatory Th1 cells


CD4+ Th1 cells release inflammatory cytokines that affect blood vessels (TNF-), recruit chemokines and
activate macrophages (IFN-)
Can be protective as well as pathological
Primary role in defence against intracellular pathogens
DTH inducers:
- intracellular parasites (Leishmania)
- intracellular bacteria (Mycobacteria)
- intracellular fungi (candida)
- intracellular viruses (Herpes simplex)
If the source of the antigen is not
eradicated chronic stimulation
granuloma formation
If the antigen is not a microbe, DTH
produces tissue injury without
protection HYPERSENSITIVITY

The DTH response consists of two phases:


Sensitization phase
Effector phase
36

MCD Immunology

Alexandra Burke-Smith

Clinical and histological appearance


Tuberculin-type hypersensitivity
Reaction characterised by an area of red firm swelling of the skin
Maximal 48-72 hrs after challenge
Histologically there is a dense dermal infiltrate of leukocytes and macrophages

T-B cell collaboration

Immunoglobulin+ B cells bind specific antigen


Ig-antigen complex is internalised, processed and antigenic peptides are presented on the B cell surface in
context with MHC class II
T helper cells with specific TCR recognise antigen-MHC complex
The T-B interactions trigger expression of CD40 ligand on T cells
CD40 ligand will interact with CD40 expressed by B cells
T cells secrete cytokines and B cells express cytokine receptors
The activated B cell then differentiates into antibody secreting plasma cell

T cell Functions

Recognition of antigenic peptides results in T cell activation and:


1. Clearance of pathogen - antigenic peptide derived from foreign pathogen
Pathological reactions can be caused by T cells
2. Autoimmunity - antigenic peptide derived from self protein
3. Rejection (transplants) - antigenic peptide derived from self protein of transplant donor
T helper cells in relation to their cytokines
Th1 associated functions in cell-mediated immunity
Macrophage activation
DTH reaction

Cytokines involved
IFN-, TNF-
IL-2, IFN-, TNF-, IL-3, GM-CSF
37

MCD Immunology
Help for CD8 cells
Down-regulation of Th2 responses
Th2 associated functions in humoral immunity
B cell proliferation
B cell differentiation and Ig class switching
Down-regulation of Th1 responses

Alexandra Burke-Smith
IL-2
IFN-
Cytokines involved
IL-2, IL-4, IL-5
IL-2, IL-4, IL-5, IFN-, TGF-
IL-4, TGF-, IL-10

Regulator T Cells

Some T cells differentiate into regulatory cells in the thymus or in peripheral tissue
Regulatory T cells inhibit the activation of naive and effector T cells by CONTACT-DEPENDENT INHIBITION or
by CYTOKINE-MEDIATED INHIBITION
Regulate activation and effector functions of other T cells
Natural; 5-10% in body; from thymus and important in autoimmunity
Down-regulate immune response; both cell-to-cell and cytokine mediated
Antigen specific induced

Immunological Memory

Adaptive immune response in which the immune system remembers subsequent encounters with the same
pathogen
Memory responses are characterised by a faster and stronger immune response that serves to eliminate
pathogens and prevent diseases
Can confer life-long immunity to many infections, and is the basis for successful vaccination
Memory cells show qualitatively different and quantitatively enhances responses upon re-exposure

T cell memory

T cells do not undergo isotype switching or affinity maturation


CD45RA expression allows to differentiate between nave memory cells
Expression of the chemokine receptor CCR7, which controls homing to secondary lymphoid organs, allows a
further subdivision of human memory T cells
CCR7- CD45RA- memory cells = effector memory T cells = TEM
CCR7+CD45RA- memory cells = central memory T cells = TCM
TEM:
display immediate effector function
TCM:
lack immediate effector function, differentiate into CCR7- effector cells after secondary stimulation
38

MCD Immunology

Alexandra Burke-Smith

Following Leishmania infection


(a) The initial events that trigger
development of the most effective CD4+
T-cell response for controlling Leishmania
infection require a primary infection with
live parasites.
The combined stimulus provided by
activated macrophages and their
interaction with nave CD4+ T cells leads
to the development of an effector T-cell
response.
The effector T cells produce cytokines and interact with macrophages and/or monocytes, increasing their
capacity to present antigen (Ag), activate other T cells and kill intracellular parasites.
During this process, effector T cells leave the node and also home to infection sites. The majority of effector
T cells die and, through a series of poorly defined signals, memory T cells are generated.
(b) At least two populations of memory T cells are generated during the immune response CM T cells (i) and
EM T cells (ii) each of which can be defined by a group of functional characteristics and phenotypic
markers.
It is unclear what the specific signals are that induce the formation and maintenance of each subpopulation,
CM T cells are maintained in the absence of live parasites, whereas EM T cells require the presence of live
parasites.
(c) Following secondary stimulation, CM and EM T cells are poised to respond to the challenge, albeit with key
differences.
EM T cells can home immediately to infected lesion sites and produce effector cytokines, whereas CM T cells
must first pass through a phase of activation and differentiation to generate effector cells.
The importance of this delay on inducing rapid protection, and the extent to which CM T cells are influenced
by the EM T-cell compartment are unclear.
Because the most effective protection is provided when both CM and EM T cells are generated and
maintained, a balance of both subsets is important for maximal protection.

39

MCD Immunology

Alexandra Burke-Smith

8. Host Defence Overview


Professor Peter Openshaw (p.openshaw@imperial.ac.uk)

Immunity

Protection from infection


Immune response: reaction to a threat (antigen)
Immune system: cells and molecules leading to protection
Role: to defend against viruses, bacteria, fungi, parasites, i.e. dangerous but not SELF things
Our cells are outnumbered by our bacteria 10:1

Modes of transmission of disease

Respiratory
GI tract
Venereal
Zoonoses (vectors)

Defences

Coughing
Sneezing
Mucus
Cilia
Rapid cell turnover
Antimicrobial peptides produced by phagocytes and epithelial cells

General Surface Defence

Mechanical
Epithelial tight junctions
Skin- waterproofed by fatty secretions
Social conditioning, e.g. wahsing
Chemical
Fatty acids- skin
Enzymes: lysozyme (saliva, sweat and tears), pepsin (gut)
Low pH (stomach, sweat)
Antibacterial peptides (Paneth cells in intestine)
Microbiological:
Normal flora compete for nutrients/attachment sites
Production of antibacterial substances

Overview of the Immune Response

Pre-infectionfirst line
Avoidance
Small
Taste
Mucus
Physical barriers
40

MCD Immunology

Alexandra Burke-Smith

Surface environment
Early infectionsecond line
Phagocytes
Opsonins
Some lymphocytes
Interferons
Acute phase proteins
Toll-like receptors

Late infectionspecific
- T cells
- Antibody responses
General Trend: Increase in learning and specificity, decrease in breadth of response

Innate Immune System


Innate Sensing
Stranger Model
- PAMPs (pathogen associated molecular patterns) are recognised by dendritic cells
- DC maturation and migration to lymph node

Danger Model
Necrotic cell death
DAMPS (damage associated molecule patterns) released, which bind to receptor on DC
DC maturation and migration to lymph node

Phagocytes

Cells that engulf invaders


Antigen is destroyed in intracellular vesicles
Includes macrophages, neutrophils
41

MCD Immunology

Alexandra Burke-Smith

Antimicrobial Defence Mechanisms


Involves neutrophils, Eosinophils, basophils and mast cells
Toxic oxygen, e.g. superoxide O2, H2O2
Toxic nitrogen oxides, e.g. NO
Enzymes, e.g. lysozyme
Antimicrobial peptides, e.g. defensins
DNA nets
Virus Recognition Pathways

Chemical Signals
Interferons
- TYPE I/III: a/b/l
o activates NK cells
o upregulates MHC, Mx
proteins
o activates RNase L, PKR
o induces anti-viral state
- TYPE II: IFNg
o proinflammatory
o Th1 cytokine
o immune interferon

42

MCD Immunology

Alexandra Burke-Smith

Chemokines
Cytokines
Innate Cellular Defences
Natural Killer Cells
- kill host cells that are:
o Infected
o Transformed
o Stressed
- Important in viral
infections.
o Viruses evade NK
cell killing
o NK deficiency
leads to increased
infections
- Important early source of
cytokines
- Shape adaptive immune responses

The acquired Immune System


B cells

There are 1014 potential different antibodies (VDJ combinations)


Each antibody recognises one specific shape/charge combination
Each B cell expresses one unique antibody
Antibody binds antigen
Antibody is membrane bound or secreted
Role of antibodies: neutralisation, opsonisation, complement activation
Antibodies may trigger cell mediated cytotoxicity (ADCC)

T cells

Each T cell expresses one TCR


There are potentially 10^18 different TCRs
Each TCR sees a specific
combination of MHC and
peptide at high affinity

Antigen processing and


presentation

Protection against specific


microbes
Defence against bacteria

Surface defences
(mechanical and chemical)
Antibody opsonisation
43

MCD Immunology

Alexandra Burke-Smith

Complement (alternative pathway) causing lysis/opsonisation


Phagocytosis
Release of inflammatory mediators and acute phase proteins (also opsonins) etc.
Fever

Mucosal defences
Mannan binding proteins
Antimicrobial peptides
Enzymes e.g. lysozyme
Mucosal lymphocytes
Secretory IgA
Special antigen sampling
o Waldeyers ring
o Peyers patches
o Dendritic cell networks
Defences against viruses

Surface defences
Interferons
Inflammatory mediators and acute phase proteins/opsonins etc.
NK cells
Antibody, complement, ADCC
T cells

Flu Pathogenesis
Factors that affect severity of infection
RNA sequence
Viral load
Environment
DNA of host
Viral Strategies

block IFN induction


decoy IFN receptors
perturbation of IFN signaling
downregulate ISGs

How infection causes disease

Normal response
Good immune response
Appropriate regulation
Pathogen defeated
Immune defect
Poor immune response
Poor control of infection
High pathogen load
Poor T regulatory cells
Defective regulation
44

MCD Immunology
-

Alexandra Burke-Smith

Normal viral load


Uncontrolled immune response
Sustained, enhanced response

LECTURERS NOTES
Why do we have an immune system?
It can be argued that the immune system has developed to provide us with a survival advantage against infection,
and that all other functions are a by-product. Our internal and external surfaces are bathed in microbes. We inhale
potentially lethal microbes with every breath that we take, and our cells are outnumbered by our bacteria by 10:1,
which form about 3% of our body mass. The essential challenge of the immune system is to remain indifferent to
non-pathogenic microbes, while responding rapidly and appropriately to the constant microbial onslaught.

The physical and chemical barriers: innate defence


A vital barrier to the entry of pathogens is the so-called wall of death, made up of surface layers of skin that are
dead or dying and constantly being shed. Unless the skin is broken by trauma or biting insects, it is very unlikely that
infection can gain access except through the lung or gut. The lung and gut are organs specialised to provide a large
area of contact with the environment, necessary for gas exchange and absorption of food and water. The mucosal
surfaces turn over at a very fast rate, with all the superficial cells being sloughed within a few hours or days. Any
microbe that attaches to these cells is soon lost along with the dead and dying cells. The mucocilliary system in the
lungs clears microbes from the lung; Cystic fibrosis patients cannot form mucus normally and suffer from recurrent
respiratory infections. Mechanical defence should not be underestimated.
There are also chemicals (fatty acids, enzymes etc.) that bathe the skin and other body surfaces: Lysozyme in our
tears digests bacterial cell walls and the acid in our stomachs kill many of the microbes we ingest. The normal flora
in our gut prevents other bacteria from gaining a foothold, so affecting susceptibility to gut infections following
antibiotic treatment.

Detection of Pathogens by the Innate Immune System


The innate immune system is our first line of defence against infection. Its components are generally innate, i.e. preformed, and rapidly react to pathogen invasion. Classically, the innate system does not adapt and therefore shows
no memory response.
Recognition is based on the sensing of common molecular patterns on the surface of pathogens, a signal that is
contingent on whether or not that particular foreign component is normally present at the site concerned.
Therefore, a molecular pattern may be sensed at the surface and lead to no response, whereas the same molecular
pattern sensed in the cytosol may induce a vigorous reaction. The toll-like receptors (TLR) are an excellent example
of this pathogen sensing system. 204
The complement system is a pre-formed protein cascade which can rapidly punch holes in the outer membrane of
microbes, coat them for phagocytosis (opsonisation) and produces chemoattractants which recruit cellular
components of the immune system.

Chemical signals: interferons, chemokines and cytokines


The production of interferons is also crucial to host defence. Interferons are soluble low molecular weight mediators
released by cells in response to infection, that act both on the cell that releases them (autocrine action) and on other
neighbouring cells (paracrine) to induce an antiviral state and increase defence. The type 1 interferons activate
natural killer (NK) cells and increase the expression of molecules involved in processing and presenting viral proteins
45

MCD Immunology

Alexandra Burke-Smith

on the cell surface. The importance of the interferon system to viruses is shown by the very large number of viruses
that have evolved mechanisms to block the synthesis and actions of interferons.
Low molecular weight mediators are also very important in recruiting other cells to the site of information. Cells that
circulate in the blood and lymph migrate out into the tissues in response to infection, particular combinations of
mediators attracting particular cells (by secretion of chemoattractants called chemokines). Neutrophils, for
example, are attracted by a chemokine called interleukin 8 (IL-8). The eosinophils, on the other hand respond to
eotaxin or RANTES.
Cytokines are chemical signals used for communication by the immune system. They may have local and systemic
effects and direct the extent and the nature of the immune response. For example, Interferon-gamma can be
produced by T cells to enhance activation of macrophages. The cytokine TNF-alpha has many systemic effects
associated with infection, including fever and weight loss.

Innate cellular defences


Once in the tissues, the inflammatory cells produce additional chemoattractive or activating mediators, and may
themselves be phagocytic (e.g. they take up particles that are degraded by vesicles within the cells). Macrophages
are important phagocytes which may be tissue resident or be recruited during infection. Neutrophils, which make up
the majority of circulating leukocytes are rapidly recruited to sites of infection. Phagocytes can use their surface
receptors to directly recognise the outer surface of microbes or to recognise other components of the immune
system, including complement and antibody, that have coated or opsonised the microbe surface. The phagocytes
defence mechanisms include toxic enzymes, reactive radicals and defensins that are produced in the phagosome
once the pathogen has been taken up.
Natural killer (NK) cells are regulated by a combination of inhibitory and stimulatory receptors. Surface receptors on
NK cells that recognise a normal cell (e.g. one displaying class I major histocompatibility complexes or MHC I) stops
the NK cell from becoming active. Lack of MHC on the surface of the cell may indicate that a virus is trying to hide in
the cell. On the other hand, a stimulatory receptor may be triggered by recognition of cell surface proteins on other
cells that signify an abnormal state of infection or transformation, leading to NK activity.
NK cells form a bridge between the innate and the acquired immune system. They kill abnormal or infected cells; if
they are defective (e.g. in rare inherited deficiency states), common virus infections tend to be severe and can be
fatal. They are an important source of some of the mediators produced by classic T-cells (see below). By producing
different combinations of T-cell cytokines, they can help to shape the adaptive immune response.

T and B cells (the acquired immune system)


Acquired immune responses are highly specific to each antigen and result in memory of that antigen. The acquired
immune system can be divided into T-cells and B-cells. Both of these originate from the bone marrow and circulate
in the blood, but T-cells need to pass through the thymus to mature. T and B cells recognise specific antigens using
their surface receptors; each T or B cell will recognise only one antigen. When these cells mature cells with a huge
diversity of receptors are generated by random reassortment of the genes encoding the receptors. Because this
process is random, there is a risk that autoreactive T and B cells are produced. These cells are usually eliminated or
regulated but autoimmune disease can result, if these processes fail.
B-cells have antibody on the surface as their receptor, and secrete soluble antibody that is able to bind to an almost
infinite variety of protein or non-protein antigens. Each B-cell represents a clone, able to produce only one exact
variety of antibody. The antibody can bind directly to the surface of pathogens so helping the pathogen to be
engulfed by a phagocyte or punch holes in the membrane of the pathogen using the complement system.
Alternatively, antibodies may neutralise a pathogen, blocking its surface receptors and preventing it from attaching
to or infecting host cells.
46

MCD Immunology

Alexandra Burke-Smith

T-cells are quite different. They do not recognise the molecular surface, shape and charge of antigen, but instead
recognise sequences of peptide from digested antigens presented by antigen presenting cells. The T-cell receptor
locks on to MHC surface proteins which are of two types. MHC I is present on all nucleated cells, under normal
circumstances. There is a cleft on the external tip of this protein that holds a short peptide signature, representing a
digest fragment of internally synthesised proteins. If this is a normal host protein, T-cells detect the presence but are
selected not to respond strongly. If it is a novel sequence, the T-cells recognise it as foreign and respond strongly. On
the other hand, the MHC II has an external cleft that bears a digestion fragment of protein that has been picked up
from outside a professional antigen presenting cell. These professionals include dendritic cells, macrophages and
some B-cells. MHC II is not present on ordinary cells.
T-cells with a helper function (those recognising peptide presented by MHC II) are often subdivided according to the
soluble mediators that they produce. Th1 cells classically make interferon gamma and tumour necrosis factor (TNF).
On the other hand Th2 cells make IL-5, IL-4, IL-9 and IL-13. These are mostly involved in allergic responses and lead
to eosinophil recruitment. However, the situation is getting ever more complex; it has recently been shown that
there are cells specialised to produce IL-17 (Th17) and various types of regulatory T-cell that make combinations of
inhibitory cytokines.
Regulatory T cells can also dampen immune responses by depriving other cells of the immune system of vital factors
(like IL-2) or by acting on dendritic cells to inhibit activation.

Protection against specific microbes


The key defences against bacteria are the intact surfaces of the body, antibody, complement, phagocytosis and the
acute phase proteins (which are opsonins, and bind in a relatively non-specific way to bacteria). On the other hand,
defences against viruses include the surface defences, interferons, inflammatory mediators, NK-cells, antibody and
T-cells.
We can exploit the ability of the immune system to remember previous exposure to specific antigens in developing
protective vaccines. If the immune system encounters a foreign substance for the first time, it is required to
recognise the material as foreign and then to expand the number of cells that recognise that specific antigen before
it can mount a full T and B-cell response. However, on second encounter the response is very much more rapid and
vigorous (more antibody is produced) and better (antibody is of higher affinity). Indeed, 206some vaccines lead to
very long lasting antibody that may be enough alone to protect against infection.
Since vaccination was popularised by Edward Jenner, many different vaccines have been introduced to protect
against the majority of the severe life threatening infections that were so prevalent only a century ago. It is very rare
to see cases of tetanus, diphtheria, typhus, anthrax or measles, except in people who have not received the benefit
of vaccination.
However, these medical marvels are only available to people living in well-resourced parts of the world, and about 3
million children die every year because they have not been given standard vaccines that would have otherwise have
saved their lives. Perhaps good, stable political systems should be regarded as a crucial component of our defence
against the microbial world.
Major challenges in the future are to control the immune response when it causes disease (in allergy, autoimmunity,
in toxic shock and transplantation, for example). We also need a better understanding of why the immune system
fails to protect us against some infections (such as HIV) and in cancer, and design novel strategies for enhancing
protective immune responses.

47

Anda mungkin juga menyukai